iDEL Therapeutics: Funding, Investors & Team (Sep 2026)
iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
iDEL Therapeutics has raised $10.4M across 1 funding round on record, the most recent a Seed of $10.4M announced in Mar 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
iDEL Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
iDEL Therapeutics Funding Rounds
iDEL Therapeutics Founders and Leadership Team
Contact details for the iDEL Therapeutics team: 1 has a LinkedIn profile.
Start 14-day free trial →iDEL Therapeutics Funding Compared to Other Biotechnology Startups
iDEL Therapeutics' latest round of $10.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like iDEL Therapeutics in Biotechnology and Dortmund
Companies Similar to iDEL Therapeutics
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
iDEL Therapeutics Funding FAQs
What does iDEL Therapeutics do?
iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
How much funding has iDEL Therapeutics raised?
iDEL Therapeutics has raised $10.4M across 1 round on record. The most recent is a Seed of $10.4M announced in Mar 2026.
When did iDEL Therapeutics last raise funding?
iDEL Therapeutics' most recent funding round on record is a Seed of $10.4M, announced in Mar 2026.
Who founded iDEL Therapeutics?
FundedIQ lists Marcus Kostka Idel Therapeutics Gmbh (Founder) at iDEL Therapeutics.
Where is iDEL Therapeutics headquartered?
iDEL Therapeutics is based in Dortmund, Nordrhein-Westfalen, Germany.
How many employees does iDEL Therapeutics have?
iDEL Therapeutics is in the 1-10 employee band.
How does iDEL Therapeutics' funding compare to other Biotechnology startups?
iDEL Therapeutics' latest round of $10.4M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's iDEL Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for iDEL Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.